Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01662284 · ClinicalTrials.gov registry record
Study of 124I-NM404 in Advanced Solid Malignancies
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 12
- Enrollment target
NCT01662284 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 12 participants.
The verdict
NCT01662284 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 12 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the use of investigational compound 124I-NM404 for accurate detection and characterization of a wide variety of solid primary and metastatic malignancies anywhere in the body.
Interventions
- DRUG 124I-NM404
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 12 participants |
| Start Date | 2012-07 |
| Est. Completion | 2016-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01662284
The ClinicalTrials.gov registry entry for NCT01662284 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 12 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which 124I-NM404 is the first listed.
NCT01662284 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01662284 about?
NCT01662284 is a clinical study titled "Study of 124I-NM404 in Advanced Solid Malignancies". The purpose of this study is to assess the use of investigational compound 124I-NM404 for accurate detection and characterization of a wide variety of solid primary and metastatic malignancies anywhere in the body.
What is the current status of trial NCT01662284?
This trial is currently terminated. The enrollment target is 12 participants. The study started on 2012-07. Estimated completion is 2016-05.
What interventions are being tested in trial NCT01662284?
The interventions under investigation include: 124I-NM404 (DRUG).
Who is sponsoring clinical trial NCT01662284?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.